On November 1, 2020, Novak Company adopted a stock-option plan that granted options to key executives to purchase 36,900 shares of the companys $11 par value common stock. The options were granted on January 2, 2021, and were exercisable 2 years after the date of grant if the grantee was still an employee of the company. The options expired 6 years from date of grant. The option price was set at $40, and the fair value option-pricing model determines the total compensation expense to be $553,500. All of the options were exercised during the year 2023: 24,600 on January 3 when the market price was $65, and 12,300 on May 1 when the market price was $75 a share. Prepare journal entries relating to the stock option plan for the years 2021, 2022, and 2023. Assume that the employee performs services equally in 2022 and 2023